Cannabis Stock Explosion in Progress

Aphria, Inc. APHA – Options Recap

Our sole point of focus in terms of fresh options plays in yesterday morning’s premarket report, was a tight range of calls in the APHA chain on the heels of the company’s earning report- the APHA Weekly $10-11 Calls to be exact. Despite a down day for the markets at large, we saw this cannabis stock buck the trend on the strength of increased price targets relating to the company’s impending merger with Tilray, Inc. TLRY, another pot stock with which we’ve had some experience in the past.

The gains on our target contracts for the day yesterday were quite impressive as you’ll see below, but based on the premarket activity we’re observing this morning, we expect the following ranges and total possible gains to explode at the open today.  Read on to find the expanded set of targets that we’re going to formulate for APHA for today and into next week.

APHA Weekly $10-11 Calls
$10:
 .70-2.25 (+221%)
$10.50: .40-1.70 (+325%)
$11: .28-1.20 (+329%)

As we said above, we expect those figures to increase today, and going forward we’re going to add the APHA Weekly $13-14 Calls, and the APHA 01/22 $15 Calls into our pool of tracked contracts. We’ll also include the TLRY Weekly $21-22 Calls just for good measure.

We’re also going to include a wide range of OTC-traded cannabis penny stocks to track below, as the legislative environment is about to shift dramatically toward favorable conditions for federal reclassification, and the business opportunities it will provide should be like nothing we’ve seen to date.

______

Fresh Options Idea:
W 02/12 $340-335 Puts


OTC Cannabis Watchlist:
GRNH, TRTC, CNGT, CBMJ, HEMP, SGMD, KALY, GCAN, HMPQ, INQD, MJNA, CCAN, OWCP, UAMM, DKMR, AMMJ, SRNA, BUDZ

Blue Horseshoe Stocks: HAS Recap, Green Rush 2.0

Hasbro, Inc. HAS – Options Idea

Yesterday, after noticing the recording of new 6-month lows on HAS the day prior, coupled with a premarket earnings beat, we signaled a range of options ideas in our report.

Our targeted contracts were the HAS Weekly $79-81 Calls,with the stipulation that if the stock broke the $81-mark, that we’d correspondingly roll up our strike price a level. Based on the activity in HAS, there was literally no wrong answer, as all of the contracts mentioned provided us with a shot at excellent single-session gains.

$79 Calls – Range: 1.50-6.63 – Max Gain: 342%
$79.50 Calls – Range: 1.10-2.92 – Max Gain: 165%
$80 Calls – Range: .83-5.79 – Max Gain: 597%
$80.50 Calls – Range: .62-2.20 – Max Gain: 255%
$81 Calls – Range: .50-5.13 – Max Gain: 926%
$82 Calls – Range:  .24-1.25 – Max Gain: 421%

_____

Fresh Options Idea:

With NFLX beating on earnings yesterday post-market, we’ll signal a range of contracts to watch there as well. We’re particularly interested in tracking the NFLX Weekly $117-120 Calls.



The Start of Green Rush 2.0?

A couple of years ago, when marijuana stocks first began to emerge, and the march toward legalization in many places began, we termed it a ‘Green Rush’. It was a historical few months of exponential gains for anything even remotely tied to the cannabis space.

We’ve never stopped monitoring the sector, which, compared to practically any other, is still in its infancy. Recently, we’ve been reminding our readers to keep a keen eye as well, for if all things remain equal, it’s likely that California will become a recreational marijuana state in just a few week’s time. California is the most populous state in the country, and the proposed bill is more comprehensive than anything we’ve seen in the other states where prohibition laws have been scrapped. The ripple effect from the world’s sixth largest economy legalizing marijuana and its by-products will be significant indeed.

In fact, the effect of the anticipation is already kicking the tires on what could very well be Green Rush 2.0. Out of the top 14 traded stocks on yesterday’s scanner (pictured below) all but one have some link to the pot sector. Every last one of them are stocks that we’ve talked about in the past, and all of them (and more) will be high up on our working watchlist over the next several weeks.

We warned our readers of the first Green Rush before it kicked into full swing back in 2014, and we’ve been doing our best to do the same thing in advance of the forthcoming California vote on Prop 64, which should ultimately prove to be a real game-changer.

The symbols pictured above will also serve as today’s Extended Watchlist, in addition to FLDM, a declining stock that we want to put on bottom watch.


Blue Horseshoe Stocks: GLBS Recap & More

Globus Maritime Ltd. GLBS – Update

GLBS was among the shipping sector plays that we were talking about in Friday morning’s premarket report, and it ultimately ended up being the most interesting one of the bunch. The sector as a whole seemed to be buzzing leading into Friday, and the activity that coincided in the GLBS chart, which made several tradeable swings on the day.

It started from the opening bell when the stock initially ran impressively from .66-1.63 for gains of up to 147% right off the bat. We then observed a pullback whereafter the stock bounced from .95 on up to the high of day at 1.78; that added an 87% rip. Subsequent to that, yet another dip and rip carried from .97-1.41, tacking on another 45% upswing.  In total, cumulative single-session gains for GLBS came in at 279% as the stock traded record volume.

We often search for plays with volatility of this magnitude because they can be excellent for quick intraday flips as GLBS demonstrated on Friday. We’ll be interested to see how it establishes itself as things get going this week. More opportunities may be on the horizon.



Bottom Watchlist

The following trio of stocks caught our interest off of our bottom-play scan this morning. In the case of RCPI we’ve got a stock that’s been steadily beaten back into heavily oversold territory, while BIOC and STX have both violently gapped down in recent sessions. We’ll have all three on extended watch for potential bounce-play opportunities.

Rock Creek Pharmaceuticals, Inc. RCPI
Biocept Pharmaceuticals,Inc. BIOC
Seagate Technology Public Ltd. Co. STX

We’ve also included a conglomerate snapshot of all three charts:


Extended Watchlist:
SPOM, SRNA, SRPT, LBSR, GOFF